{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:52:41Z","timestamp":1781578361648,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2023A1515010294"],"award-info":[{"award-number":["2023A1515010294"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shenzhen High-level Hospital Construction Fund and Peking University Shenzhen Hospital Scientific Research Fund","award":["KYQD2024355"],"award-info":[{"award-number":["KYQD2024355"]}]},{"name":"Shenzhen Science and Technology Program","award":["JCYJ20220530160207015"],"award-info":[{"award-number":["JCYJ20220530160207015"]}]},{"name":"Guangdong Provincial Key R&D Programme","award":["2022B1111020001"],"award-info":[{"award-number":["2022B1111020001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04952-y","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:06:03Z","timestamp":1777478763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["BET1 serves as a prognostic indicator and promotes cancer proliferation in glioblastoma multiforme"],"prefix":"10.1007","volume":"17","author":[{"given":"Yu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changmeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"suppl5","key":"4952_CR1","first-page":"v1","volume":"18","author":"QT Ostrom","year":"2016","unstructured":"Ostrom QT, Gittleman H, Xu J, et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009\u20132013. Neurooncology. 2016;18(suppl5):v1\u201375.","journal-title":"Neurooncology"},{"key":"4952_CR2","doi-asserted-by":"publisher","first-page":"115090","DOI":"10.1016\/j.bcp.2022.115090","volume":"201","author":"S Kannan","year":"2022","unstructured":"Kannan S, Murugan AK, Balasubramanian S, Munirajan AK, Alzahrani AS. Gliomas: Genetic alterations, mechanisms of metastasis, recurrence, drug resistance, and recent trends in molecular therapeutic options. Biochem Pharmacol. 2022;201:115090.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"4952_CR3","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1002\/jcp.30067","volume":"236","author":"BL Tang","year":"2021","unstructured":"Tang BL. SNAREs and developmental disorders. J Cell Physiol. 2021;236(4):2482\u2013504.","journal-title":"J Cell Physiol"},{"issue":"12","key":"4952_CR4","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/tra.12524","volume":"18","author":"T Wang","year":"2017","unstructured":"Wang T, Li L, Hong W. SNARE proteins in membrane trafficking. Traffic. 2017;18(12):767\u201375.","journal-title":"Traffic"},{"issue":"7","key":"4952_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.6026\/97320630014361","volume":"14","author":"GK Khurana","year":"2018","unstructured":"Khurana GK, Vishwakarma P, Puri N, Lynn AM. Phylogenetic Analysis of the vesicular fusion SNARE machinery revealing its functional divergence across Eukaryotes. Bioinformation. 2018;14(7):361\u20138.","journal-title":"Bioinformation"},{"key":"4952_CR6","doi-asserted-by":"publisher","first-page":"105469","DOI":"10.1016\/j.phrs.2021.105469","volume":"165","author":"F Chen","year":"2021","unstructured":"Chen F, Chen H, Chen Y, et al. Dysfunction of the SNARE complex in neurological and psychiatric disorders. Pharmacol Res. 2021;165:105469.","journal-title":"Pharmacol Res"},{"key":"4952_CR7","doi-asserted-by":"crossref","unstructured":"Barillaro M, Schuurman M, Wang R. \u03b21-Integrin-A key player in controlling pancreatic beta-cell insulin secretion via interplay with SNARE proteins. Endocrinology. 2022;164(1).","DOI":"10.1210\/endocr\/bqac179"},{"key":"4952_CR8","doi-asserted-by":"crossref","unstructured":"Liu H, Dang R, Zhang W, Hong J, Li X. SNARE proteins: core engines of membrane fusion in cancer. Biochim Biophys Acta Rev Cancer. 2024:189148.","DOI":"10.1016\/j.bbcan.2024.189148"},{"issue":"12","key":"4952_CR9","doi-asserted-by":"publisher","first-page":"e13787","DOI":"10.15252\/emmm.202013787","volume":"13","author":"S Donkervoort","year":"2021","unstructured":"Donkervoort S, Krause N, Dergai M, et al. BET1 variants establish impaired vesicular transport as a cause for muscular dystrophy with epilepsy. EMBO Mol Med. 2021;13(12):e13787.","journal-title":"EMBO Mol Med"},{"issue":"10","key":"4952_CR10","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1083\/jcb.201808149","volume":"218","author":"T Miyagawa","year":"2019","unstructured":"Miyagawa T, Hasegawa K, Aoki Y, et al. MT1-MMP recruits the ER-Golgi SNARE Bet1 for efficient MT1-MMP transport to the plasma membrane. J Cell Biol. 2019;218(10):3355\u201371.","journal-title":"J Cell Biol"},{"issue":"3","key":"4952_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/jama.2009.997","volume":"302","author":"M Bredel","year":"2009","unstructured":"Bredel M, Scholtens DM, Harsh GR, et al. A network model of a cooperative genetic landscape in brain tumors. JAMA. 2009;302(3):261\u201375.","journal-title":"JAMA"},{"issue":"2","key":"4952_CR12","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1200\/JCO.2005.02.9405","volume":"24","author":"M Bredel","year":"2006","unstructured":"Bredel M, Bredel C, Juric D, et al. Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas. J Clin oncology: official J Am Soc Clin Oncol. 2006;24(2):274\u201387.","journal-title":"J Clin oncology: official J Am Soc Clin Oncol"},{"issue":"19","key":"4952_CR13","doi-asserted-by":"publisher","first-page":"8679","DOI":"10.1158\/0008-5472.CAN-05-1204","volume":"65","author":"M Bredel","year":"2005","unstructured":"Bredel M, Bredel C, Juric D, et al. Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. Cancer Res. 2005;65(19):8679\u201389.","journal-title":"Cancer Res"},{"issue":"5","key":"4952_CR14","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00401-015-1409-0","volume":"129","author":"M Weller","year":"2015","unstructured":"Weller M, Weber RG, Willscher E, et al. Molecular classification of diffuse cerebral WHO grade II\/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups. Acta Neuropathol. 2015;129(5):679\u201393.","journal-title":"Acta Neuropathol"},{"key":"4952_CR15","doi-asserted-by":"crossref","unstructured":"Li T, Fu J, Zeng Z et al. TIMER2. 0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509\u201314.","DOI":"10.1093\/nar\/gkaa407"},{"issue":"1","key":"4952_CR16","doi-asserted-by":"publisher","first-page":"5679","DOI":"10.1038\/s41467-019-13528-0","volume":"10","author":"F Chen","year":"2019","unstructured":"Chen F, Chandrashekar DS, Varambally S, Creighton CJ. Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers. Nat Commun. 2019;10(1):5679.","journal-title":"Nat Commun"},{"key":"4952_CR17","doi-asserted-by":"crossref","unstructured":"De Bruijn I, Kundra R, Mastrogiacomo B et al. Analysis and visualization of longitudinal genomic and clinical data from the AACR project GENIE biopharma collaborative in cBioPortal. Cancer Res. 2023;83(23):3861\u20137.","DOI":"10.1158\/0008-5472.CAN-23-0816"},{"key":"4952_CR18","unstructured":"Wang L-B, Karpova A, Gritsenko MA et al. Proteogenomic and metabolomic characterization of human glioblastoma. Cancer Cell. 2021;39(4):509\u201328. e520."},{"issue":"9","key":"4952_CR19","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/cas.12214","volume":"104","author":"A Kawaguchi","year":"2013","unstructured":"Kawaguchi A, Yajima N, Tsuchiya N, et al. Gene expression signature-based prognostic risk score in patients with glioblastoma. Cancer Sci. 2013;104(9):1205\u201310.","journal-title":"Cancer Sci"},{"issue":"10","key":"4952_CR20","first-page":"28","volume":"128","author":"TM Therneau","year":"2015","unstructured":"Therneau TM, Lumley TJRTD. Package \u2018survival\u2019. 2015;128(10):28\u201333.","journal-title":"Package \u2018survival\u2019"},{"key":"4952_CR21","doi-asserted-by":"crossref","unstructured":"Blanche P, Dartigues JF, Jacqmin-Gadda, HJSim. Estimating and comparing time\u2010dependent areas under receiver operating characteristic curves for censored event times with competing risks.Stat Med. 2013;32(30):5381\u201397.","DOI":"10.1002\/sim.5958"},{"key":"4952_CR22","doi-asserted-by":"crossref","unstructured":"Fourment M, Gillings MRJB. A comparison of common programming languages used in bioinformatics. BMC Bioinformatics. 2008;9(1):82.","DOI":"10.1186\/1471-2105-9-82"},{"key":"4952_CR23","doi-asserted-by":"crossref","unstructured":"Qiu M-j, Liu L-p, Jin S et al. Research on circadian clock genes in common abdominal malignant tumors. Chronobiol Int. 2019;36(7):906\u201318.","DOI":"10.1080\/07420528.2018.1477792"},{"key":"4952_CR24","doi-asserted-by":"crossref","unstructured":"Li Y, Ge X, Peng F, Li W, Li JJJG. Exaggerated false positives by popular differential expression methods when analyzing human population samples. Genome Biol. 2022;23(1):79.","DOI":"10.1186\/s13059-022-02648-4"},{"key":"4952_CR25","doi-asserted-by":"crossref","unstructured":"Chen D, Xu L, Xing H et al. Sangerbox 2: enhanced functionalities and update for a comprehensive clinical bioinformatics data analysis platform. Imeta. 2024;3(5):e238.","DOI":"10.1002\/imt2.238"},{"key":"4952_CR26","doi-asserted-by":"crossref","unstructured":"Yu G, Wang L-G, Han Y, He Q-YJO. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","DOI":"10.1089\/omi.2011.0118"},{"key":"4952_CR27","doi-asserted-by":"crossref","unstructured":"Ritchie ME, Phipson B, Wu D et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47\u201347.","DOI":"10.1093\/nar\/gkv007"},{"issue":"3","key":"4952_CR28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34(3):267\u201373.","journal-title":"Nat Genet"},{"issue":"43","key":"4952_CR29","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4952_CR30","first-page":"ELIXIR","volume":"9","author":"L Kolberg","year":"2020","unstructured":"Kolberg L, Raudvere U, Kuzmin I, Vilo J, Peterson HJF. gprofiler2\u2013an R package for gene list functional enrichment analysis and namespace conversion toolset g. Profiler. 2020;9:ELIXIR\u2013709.","journal-title":"Profiler"},{"key":"4952_CR31","doi-asserted-by":"crossref","unstructured":"Cui H, Zhao G, Lu Y et al. TIMER3: an enhanced resource for tumor immune analysis. 2025:gkaf388.","DOI":"10.1093\/nar\/gkaf388"},{"issue":"1","key":"4952_CR32","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1038\/s41467-024-46343-3","volume":"15","author":"KB Lupo","year":"2024","unstructured":"Lupo KB, Yao X, Borde S, et al. synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy. Nat Commun. 2024;15(1):1909.","journal-title":"Nat Commun"},{"issue":"1","key":"4952_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12943-019-1120-1","volume":"19","author":"J He","year":"2020","unstructured":"He J, Huang Z, He M, et al. Circular RNA MAPK4 (circ-MAPK4) inhibits cell apoptosis via MAPK signaling pathway by sponging miR-125a-3p in gliomas. Mol Cancer. 2020;19(1):17.","journal-title":"Mol Cancer"},{"key":"4952_CR34","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"key":"4952_CR35","doi-asserted-by":"crossref","unstructured":"Hu K, Wu W, Li Y et al. Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. EMBO Rep 2019;20(5).","DOI":"10.15252\/embr.201846166"},{"key":"4952_CR36","doi-asserted-by":"crossref","unstructured":"SongTao Q, Lei Y, Si G et al. IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma. Cancer Sci. 2012;103(2):269\u201373.","DOI":"10.1111\/j.1349-7006.2011.02134.x"},{"issue":"4","key":"4952_CR37","doi-asserted-by":"publisher","first-page":"592","DOI":"10.18632\/aging.101415","volume":"10","author":"D Jia","year":"2018","unstructured":"Jia D, Li S, Li D, Xue H, Yang D, Liu Y. Mining TCGA database for genes of prognostic value in glioblastoma microenvironment. Aging. 2018;10(4):592\u2013605.","journal-title":"Aging"},{"issue":"22","key":"4952_CR38","doi-asserted-by":"publisher","first-page":"13235","DOI":"10.1111\/jcmm.15939","volume":"24","author":"K Xiao","year":"2020","unstructured":"Xiao K, Tan J, Yuan J, et al. Prognostic value and immune cell infiltration of hypoxic phenotype-related gene signatures in glioblastoma microenvironment. J Cell Mol Med. 2020;24(22):13235\u201347.","journal-title":"J Cell Mol Med"},{"key":"4952_CR39","doi-asserted-by":"crossref","unstructured":"Han S, Zhang C, Li Q et al. Tumour-infiltrating CD4\u2009+\u2009and CD8\u2009+\u2009lymphocytes as predictors of clinical outcome in glioma. Br J Cancer. 2014;110(10):2560\u20138.","DOI":"10.1038\/bjc.2014.162"},{"key":"4952_CR40","doi-asserted-by":"crossref","unstructured":"Wu S, Yang W, Zhang H et al. The prognostic landscape of tumor-infiltrating immune cells and immune checkpoints in glioblastoma. Technol Cancer Res Treat. 2019;18:1533033819869949.","DOI":"10.1177\/1533033819869949"},{"issue":"1","key":"4952_CR41","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, et al. Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade. Cell Rep. 2017;18(1):248\u201362.","journal-title":"Cell Rep"},{"key":"4952_CR42","doi-asserted-by":"crossref","unstructured":"Perrin L, Gligorijevic B. Proteolytic and mechanical remodeling of the extracellular matrix by invadopodia in cancer. Phys Biol 2022;20(1).","DOI":"10.1088\/1478-3975\/aca0d8"},{"issue":"7","key":"4952_CR43","doi-asserted-by":"publisher","first-page":"151122","DOI":"10.1016\/j.ejcb.2020.151122","volume":"99","author":"S Iizuka","year":"2020","unstructured":"Iizuka S, Leon RP, Gribbin KP, et al. Crosstalk between invadopodia and the extracellular matrix. Eur J Cell Biol. 2020;99(7):151122.","journal-title":"Eur J Cell Biol"},{"issue":"7408","key":"4952_CR44","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nature11183","volume":"487","author":"R Straussman","year":"2012","unstructured":"Straussman R, Morikawa T, Shee K, et al. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature. 2012;487(7408):500\u20134.","journal-title":"Nature"},{"issue":"5","key":"4952_CR45","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrc1877","volume":"6","author":"R Kalluri","year":"2006","unstructured":"Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6(5):392\u2013401.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"4952_CR46","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"8","key":"4952_CR47","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","volume":"23","author":"A Christofides","year":"2022","unstructured":"Christofides A, Strauss L, Yeo A, Cao C, Charest A, Boussiotis VA. The complex role of tumor-infiltrating macrophages. Nat Immunol. 2022;23(8):1148\u201356.","journal-title":"Nat Immunol"},{"key":"4952_CR48","doi-asserted-by":"crossref","unstructured":"Arneth B. Tumor microenvironment. Medicina (Kaunas Lithuania). 2019;56(1).","DOI":"10.3390\/medicina56010015"},{"key":"4952_CR49","doi-asserted-by":"publisher","first-page":"685213","DOI":"10.3389\/fimmu.2021.685213","volume":"12","author":"S Ait Ssi","year":"2021","unstructured":"Ait Ssi S, Chraa D, El Azhary K, Sahraoui S, Olive D, Badou A. Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades. Front Immunol. 2021;12:685213.","journal-title":"Front Immunol"},{"issue":"38","key":"4952_CR50","doi-asserted-by":"publisher","first-page":"e35298","DOI":"10.1097\/MD.0000000000035298","volume":"102","author":"Y Shen","year":"2023","unstructured":"Shen Y, Zheng D, Hu D, et al. The prognostic value of tumor-associated macrophages in glioma patients. Medicine. 2023;102(38):e35298.","journal-title":"Medicine"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04952-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04952-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04952-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:18:44Z","timestamp":1781576324000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04952-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4952"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04952-y","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was approved by the Ethics Committee of Peking University Shenzhen Hospital in accordance with the guidelines for the Care and Use of Experimental Animals at Peking University Shenzhen Hospital. Consent to participate is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors give consent for publication of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"901"}}